Dynamk Capital LLC is a venture capital firm specializing in the life sciences sector, with a focus on tools, technologies, and services that facilitate the discovery, development, and production of life-saving therapies. The firm typically invests in Seed, Series A, and Series B rounds, supporting companies at various stages of growth to bring innovative solutions to market.
Notable portfolio companies include Alpenglow Biosciences, CellFE, Curi Bio, Envisagenics, Lucid Scientific, RoosterBio, Vernal Biosciences, and Xcell Biosciences. Dynamk Capital is known for its strategic investment philosophy and offers unique value-add services to its portfolio companies, leveraging deep industry expertise and a robust network to accelerate growth and innovation in the life sciences domain.
Dynamk Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages